Le rapport
Actualités vérifiées sur le financement, les sièges sociaux et les dirigeants des entreprises les plus innovantes au monde
3 rapports et plus encore
Expedition Therapeutics Raises $115M Series B for Oral DPP1 Inhibitor for COPD
Expedition Therapeutics raised an oversubscribed $115 million Series B led by General Atlantic to advance its DPP1 inhibitor EXPD-101 through Phase 2 clinical development in COPD.
AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment
Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.
Propeller Health Headquarters - Office Location & Address
Discover Propeller Health's headquarters at 432 E Washington Ave, Madison, WI 53703. Digital health company offering sensor-based platform for respiratory medication adherence and asthma management. Connected inhaler system tracking medication use and triggers to improve asthma and COPD outcomes.. Learn about the office facilities and work environment.
Affichage de 3 rapports • Page 1 • Catégorie : all
Restez en avance sur le marché
Recevez des insights hebdomadaires dans votre boîte de réception. Pas de spam, juste de l'intelligence.